JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fine, G. F.
Right arrow Articles by Davis, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fine, G. F.
Right arrow Articles by Davis, P. J.
Related Collections
Right arrow Pediatrics
Right arrow Pharmacology
Right arrow Airway

Anesth Analg 2002;95:56-61
© 2002 International Anesthesia Research Society


PEDIATRIC ANESTHESIA

The Effect on Lung Mechanics in Anesthetized Children with Rapacuronium: A Comparative Study with Mivacurium

Gavin F. Fine, MB, BCh*{ddagger}, Etsuro K. Motoyama, MD*{dagger}{ddagger}§, Barbara W. Brandom, MD*{ddagger}, Kathleen M. Fertal, BSN*, Rebecca Mutich, RRT{dagger}, and Peter J. Davis, MD*{ddagger}§

*Department of Anesthesiology and {dagger}Division of Pulmonology, Children’s Hospital of Pittsburgh; and the Departments of {ddagger}Anesthesiology and §Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Address correspondence and reprint requests to Gavin F. Fine, MB, BCh, Children’s Hospital of Pittsburgh, Department of Anesthesiology, 3705 Fifth Ave., Pittsburgh, PA 15213. Address e-mail to finegf{at}anes.upmc.edu

The administration of rapacuronium increases the risk of severe bronchospasm. There have been no studies of pulmonary function directly demonstrating airway constriction with rapacuronium in children. In this study, 10 ASA physical status I or II patients (aged 2–6 yr) were randomly divided into 2 equal groups, receiving either rapacuronium or mivacurium. Anesthesia was induced with sevoflurane and maintained with remifentanil (0.2–0.3 µg · kg-1 · min-1) and propofol (200–250 µg · kg-1 · min-1) infusions. We performed three sets of pulmonary function tests: baseline, after the administration of muscle relaxant, and after the administration of a ß2 agonist. In both groups, there were no changes in static respiratory compliance. The increase in total respiratory system resistance after the administration of rapacuronium did not reach statistical significance (214.4% ± 122.65% of baseline, P {approx} 0.1), whereas maximal expiratory flow at 10% of forced vital capacity (MEF)10 and MEFfunctional residual capacity on partial flow-volume curves by the forced deflation technique decreased markedly (53.4% ± 18.49%, P < 0.01 and 41.3% ± 27.42%, P < 0.001, respectively). With the administration of mivacurium, no changes were observed in respiratory system resistance (109.5% ± 30.28%). MEF10 decreased slightly (77.0% ± 9.03%, P < 0.005) whereas MEFFRC did not (81.2% ± 29.85%, not significant). After the administration of a ß2 agonist, all measurements returned to baseline. Thus, the administration of rapacuronium consistently results in lower airway obstruction with minimal changes in static respiratory compliance when compared with mivacurium.

IMPLICATIONS: Pulmonary function tests in the present study showed that rapacuronium consistently causes severe bronchoconstriction, confirming clinical case reports of bronchospasm. The bronchoconstriction is reversible with albuterol. Mivacurium also causes very mild subclinical bronchoconstriction.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
F. Petak, Z. Hantos, A. Adamicza, H. Gality, and W. Habre
Development of bronchoconstriction after administration of muscle relaxants in rabbits with normal or hyperreactive airways.
Anesth. Analg., July 1, 2006; 103(1): 103 - 109.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. J. Bishop, J. T. O'Donnell, and J. R. Salemi
Mivacurium and Bronchospasm
Anesth. Analg., August 1, 2003; 97(2): 484 - 485.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2002 by the International Anesthesia Research Society.